Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

被引：0
|
作者：
James Patrick Finnerty
Aravind Ponnuswamy
Prosjenjit Dutta
Ammar Abdelaziz
Hafiz Kamil
机构：
[1] Countess of Chester Hospital NHS Trust,Department of Respiratory Medicine
[2] University of Chester Medical School,undefined
[3] The Walton Centre,undefined
来源：
BMC Pulmonary Medicine | / 21卷
关键词：
Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [2] HEPATIC DISORDERS OF PIRFENIDONE OR NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) A SYSTEMATIC REVIEW
    Singla, D.
    Mahapatra, S.
    Dey, A.
    John, A.
    VALUE IN HEALTH, 2022, 25 (12) : S218 - S218
  • [3] Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
    Di Martino, Enrica
    Provenzani, Alessio
    Vitulo, Patrizio
    Polidori, Piera
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (06) : 723 - 731
  • [4] Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF)
    Koschel, D.
    Wuyts, W.
    Maher, T.
    Wijsenbeek, M.
    Martinez, F.
    Stansen, W.
    Stowasser, S.
    Richeldi, L.
    PNEUMOLOGIE, 2024, 78 : S81 - S82
  • [5] Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis ( PPF)
    Wuyts, Wim A.
    Maher, Toby M.
    Wijsenbeek, Marlies
    Koschel, Dirk
    Martinez, Fernando J.
    Stansen, Wibke
    Stowasser, Susanne
    Richeldi, Luca
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] Real-world of Nintedanib in a Spanish non-IPF progressive pulmonary fibrosis cohort
    Vicens Zygmunt, Vanesa
    Bordas-Martinez, Jaume
    Munoz-Bolano, Miriam
    Carmezim-Correia, Joao
    Belen Llanos-Gonzalez, Ana
    Domingo-Carnice, Adria
    Rodriguez-Cumplido, Dolores
    Bermudo-Peloche, Guadalupe
    Tebe-Cordomi, Cristian
    Llop-Rius, Roser
    Molina-Molina, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Nintedanib bei progressiver Nicht-IPF-Lungenfibrose – eine SubgruppenanalyseNintedanib in progressive non-IPF pulmonary fibrosis—A subgroup analysis
    Philipp Markart
    Der Pneumologe, 2020, 17 (5): : 350 - 351
  • [9] Nintedanib in progressive Non-IPF-Pulmonary Fibrosis - A Subgroup Analysis
    Markart, Philipp
    PNEUMOLOGE, 2020, 17 (05): : 350 - 351
  • [10] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345